1st Bellwether Trial Begins in Xarelto® Litigation

Xarelto Bleed Litigation
For more information about the Xarelto® internal bleeding litigation, feel free to contact Pharmaceutical Attorney Pamela A. Borgess of BORGESS LAW, LLC at (567) 455-5955 or toll-free at (844) LAW-9144.

The first of four bellwether trials in the Xarelto® (rivaroxaban) multidistrict litigation in Louisiana Federal Court is currently underway. Plaintiff Joseph Boudreaux, 74, of Lockport, La., alleges that he developed gastrointestinal bleeding after he began taking Xarelto in 2014, requiring hospitalization, numerous blood transfusions and other serious treatments. As previously reported in this blog, this litigation…

Read More

Trials Rescheduled for Xarelto Bleed Cases

Xarelto Bleed Litigation
For more information about the Xarelto® internal bleeding litigation, feel free to contact Pharmaceutical Attorney Pamela A. Borgess of BORGESS LAW, LLC at (567) 455-5955 or toll-free at (844) LAW-9144.

On September 21, 2016, U.S. District Court Judge Eldon E. Fallon reset the initial bellwether trial dates in the Xarelto® (rivaroxaban) multidistrict litigation due to the NBA All-Star game and related logistical issues it would create. As previously reported in this blog, this litigation involves hundreds of lawsuits from across the country alleging that individuals…

Read More

UPDATE ON XARELTO INTERNAL BLEEDING LAWSUITS

Pharmaceutical litigation

The Xarelto (rivaroxaban) litigation involves numerous lawsuits from across the country alleging that individuals taking Xarelto suffered severe or fatal bleeding or other injuries. They further allege that Bayer and related companies did not adequately warn prescribing physicians or consumers of the risks associated with Xarelto, including the potential for severe or fatal bleeding and…

Read More